IconOVir Bio
PrivateLast Round
Debt
Jun 6, 2023
Total Funding Raised
$97.2M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
IconOVir Bio operates in Healthcare & Life Sciences and is based in New York City, New York. Its latest recorded funding round was a Debt round in June 2023.
IconOVir Bio is a biotechnology company that develops advanced oncolytic virus therapies designed to improve cancer treatment through personalized approaches.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
IconOVir Bio Comparables
Compare IconOVir Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ImmVirx | 86% | |
| Virogin Biotech | 85% | |
| EpicentRx | 84% |
For institutional investors. Book with your work email.
IconOVir Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Debt | Jun 6, 2023 | ||||
| Series A | Jan 5, 2021 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
IconOVir Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Two River Group | Series A |
| GV | Series A |
| Vida Ventures | Series A |
| Bellco Capital | Series A |
| Logos Capital | Series A |
| Wellington Management | Series A |
| Nextech Invest | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 45% MoM.
- Feb 21, 2025
Sold oncolytic virus asset for $4 million in stock.
For institutional investors. Book with your work email.
IconOVir Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about IconOVir Bio's valuation, stock price, and market status.
Is IconOVir Bio a public or private company?
IconOVir Bio is a private company.
What is the current stock price of IconOVir Bio?
IconOVir Bio is a private company, so its shares have no public market price. Caplight tracks IconOVir Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is IconOVir Bio worth (valuation)?
Valuation information for IconOVir Bio is not publicly available.
Can I buy IconOVir Bio stock?
IconOVir Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was IconOVir Bio's last funding round?
IconOVir Bio's most recent funding round was Debt on June 6, 2023.
Who are the main investors in IconOVir Bio?
Key investors in IconOVir Bio include Vida Ventures, Nextech Invest.
Will IconOVir Bio IPO soon?
No public IPO plans have been announced for IconOVir Bio.
How can I track IconOVir Bio secondary market activity?
Caplight tracks bids, offers, and trades in IconOVir Bio's shares on secondary markets.